Scilex Holding Company, through its subsidiary Scilex Pharmaceuticals, Inc., is engaged in the development and commercialization of pharmaceutical products aimed at pain management. The company specializes in acquiring late-stage clinical products, including both generic and branded generic medications, with a particular focus on innovative delivery methods such as transdermal patches. These products are designed to address pain conditions, notably post-herpetic neuralgia. Scilex operates within the United States, Canada, Mexico, and Latin America, serving a diverse customer base through wholesalers, distributors, and retailers. Founded in 2012 and headquartered in Malvern, Pennsylvania, Scilex is dedicated to providing effective solutions for patients suffering from various pain conditions.
NioCorp Developments Ltd. is engaged in the exploration and development of mineral deposits in North America, focusing on the Elk Creek project located in Southeastern Nebraska. This project is notable for being the highest-grade niobium project in North America and is poised to become the largest producer of scandium globally. NioCorp's efforts are aimed at establishing itself as the sole U.S. producer of niobium and scandium, both of which are critical superalloy materials essential to various industries and national defense technologies. Since its incorporation in 1987 and its rebranding in 2013, the company has made significant strides in advancing the Elk Creek project, attracting investments amid challenging market conditions for metal projects. The company aims to maintain its momentum by issuing a feasibility study, launching a global capital-raising initiative, and commencing construction activities at the site. NioCorp is headquartered in Centennial, Colorado.
D-Wave Systems Inc. is a pioneer in the development and integration of superconducting quantum computers, established in 1999 and headquartered in Burnaby, Canada. The company produces various quantum computing systems, including the D-Wave Two System, and offers the D-Wave Hybrid platform for quantum-classical applications. Additionally, D-Wave provides Leap, a cloud-based service that grants users real-time access to quantum computing resources alongside development tools and educational materials. D-Wave's technology is utilized across diverse fields such as logistics, machine learning, climate modeling, and financial analysis, addressing complex problems in industries including defense, finance, and energy. The company also delivers professional services, including training and customer support, to enhance user experience and application of its quantum solutions. With additional offices in the United States and Europe, D-Wave continues to lead in both annealing and gate-model quantum computing systems.
Canoo is a Los Angeles-based company that has developed breakthrough electric vehicles that are reinventing the automotive landscape with bold innovations in design, pioneering technologies, and a unique business model that defies traditional ownership to put customers first. Distinguished by its experienced team – totaling over 350 employees from leading technology and automotive companies – Canoo has designed a modular electric platform purpose-built to deliver maximum vehicle interior space and adaptable to support a wide range of vehicle applications for consumers and businesses. For more information, please visit www.canoo.com. For Canoo press materials, including photos, please visit press.canoo.com. For investors, please visit investors.canoo.com.
Bird operates a micro-mobility platform that offers electric vehicle-sharing services, aiming to provide affordable and sustainable transportation solutions to communities worldwide. The platform enables users to create profiles, facilitating the sharing of personal electric vehicles, including electric bicycles. By coordinating with cities, Bird enhances access to environmentally friendly local transport, thereby contributing to the reduction of traffic congestion and promoting responsible alternatives to traditional motor vehicles.
Kraig Biocraft Laboratories, Inc. focuses on developing protein based fibers using recombinant DNA technology for commercial applications in the United States. It develops fibers using genetic engineering technologies for use in various target markets, including textile, specialty fiber, and technical textile industries. The company was founded in 2006 and is based in Ann Arbor, Michigan.
Virgin Orbit, LLC, based in Long Beach, California, is a space company that specializes in the development and launching of small satellites, known as smallsats. Established in 2016 as a subsidiary of Virgin.com Limited, the company offers dedicated launch services that cater to a range of clients, including commercial entities, civil organizations, and national security and defense sectors. Virgin Orbit aims to democratize access to space by providing innovative solutions for launching satellites, private astronauts, and research experiments, thereby contributing to advancements that benefit life on Earth.
Xos Trucks Inc. is a company based in North Hollywood, California, that specializes in the manufacturing of fully electric commercial vehicles. Founded in 2016, Xos develops battery-electric vehicle platforms aimed at helping commercial fleets transition from diesel to zero-emission electric delivery solutions. The company focuses on medium- and heavy-duty vehicles designed for last-mile delivery, offering performance comparable to traditional vehicles while providing lower operating costs. Xos's innovative software platform accommodates a range of medium-duty vehicle configurations, with capabilities for varying wheelbases and range requirements of up to 200 miles. The company has established its presence in Texas and Illinois, with plans to expand into Michigan and New Jersey. In addition to electric delivery trucks, Xos also develops electrified armored vehicles, further diversifying its product offerings in the electric mobility sector.
Romeo Power, Inc. is an energy technology company headquartered in Vernon, California, specializing in the design and manufacture of lithium-ion battery modules and packs specifically for commercial electric vehicles. Established in 2015, the company focuses on creating energy-dense battery systems that enhance performance and efficiency in sustainable transportation. Romeo Power's offerings include the Hermes modules for trucks and buses and the Brown Recluse passive cooling system, both designed to maximize heat transfer and integrate seamlessly into a variety of vehicle types. The company's innovative battery solutions provide safer, longer-lasting power sources with shorter charge times and greater energy density, enabling improved acceleration, range, and durability. Additionally, Romeo Power's products are customizable and scalable, optimized through a proprietary battery management system to meet diverse power requirements across different applications.
Kraig Biocraft Laboratories, Inc. focuses on developing protein based fibers using recombinant DNA technology for commercial applications in the United States. It develops fibers using genetic engineering technologies for use in various target markets, including textile, specialty fiber, and technical textile industries. The company was founded in 2006 and is based in Ann Arbor, Michigan.
Lordstown Motors Corporation is an American automobile manufacturer of electric vehicles.Lordstown Motors is completing the engineering and development of the first full-electric pickup truck.
NLS Pharma is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia. Its patient-centered approach increases the rate for success and our successful collaboration with experts across industry, academia allows for a target specific and customized approach.
Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases.
Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application. However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases.
Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases.
Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application. However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases.
The largest taxi cab company doesn’t own a single car, the largest hotel has no real estate and the biggest restaurateur doesn’t run a single kitchen. MOI aims to be the largest “Spa/Salon”, “Barbershops” “Beauty” providers in the world without any rent, employees nor overhead. OpenTable & Grubhub Combined for the Beauty Industry; Browse, Book, Pay and Rate with the Swipe of a finger.MOI is an app allowing to connect in one place all the qualified spas salons and barbershops as well as freelance qualified and vetted artists and consumers. MOI is an online booking aggregator of hair spa and beauty services that connects salons barbershops nail salons, etc... looking for customers with customers looking for grooming locations or at home services. MOI is about to launch in New York City in August 2017 . MOI is looking forward to launching in more cities in the coming year. MOI Inc. expects to launch its smart phone app allowing individuals to identify and book beauty services while conveniently identifying the specific services needed, whether it’s is a full service shaving, hair and makeup by either a professional coming to them, or at any salon or barbershops in any given geographical area, starting with NY Metro as our launching market with more than 18,000 salons and 2,000 barbershops. The “MOI” App is effortless to use, exciting and necessary. We aim to benefit both providers on the app, as well as our subscribers to become the “go – to” platform for beauty and grooming services. The company is currently only focusing on the New York market and intend to be the principal app for the entire industry. in addition the company has a (point of sale) POS that is given for free to all salons interested in having a highly efficient system, this is the only develloped by a cosmetologist Elana B, understandng the indsurty needs, the POS created is allowing to save money on receptionists and making them true hosts, as well as managing the calendar, inventory, employees, and synchronizing all for free with the app increasing bookings by 25% on average. MOI is an ambitious and advanced system taking into account (B2B needs) and B2C requirements, with qualified providers. the Only booking app rewarding exising loyal clients and exposing providers to new customers daily. MOI is an outlier of all the companies out there because it was created and envisioned by an insider to the industry Elana B, contrary to all the other platform that are created by individuals that do not understand the needs of the providers and their relationships to their customers.Nor really understand that clients need taillored services and obejctive reviews.
Medivie Therapeutics Limited, founded in 2012 and based in Hemel Hempstead, United Kingdom, specializes in the development and marketing of innovative dental devices. The company offers Laboraide, a device designed to be placed between a woman's lower and upper jaw during childbirth, promoting muscle relaxation and enhancing oxygen flow to alleviate tension. Additionally, Medivie develops modular pacifiers that support the proper development of a child's mouth structure, helping to prevent future dental issues. Their products address various health concerns, including childbirth, migraines, chronic pain, and cognitive enhancement. Medivie distributes its offerings through a network of distributors and online platforms across Asia, Latin America, the United States, Europe, and Canada. The company was co-founded by Anthony Lovat, known for his role in the OPRO Group, a leader in customized dental protectors.
NeoMedia Technologies specializes in creating interactive experiences for print and broadcast media through the use of 2D barcodes and mobile networks. By enabling users to bypass lengthy URLs and cumbersome menus, NeoMedia facilitates real-time content delivery that can be easily accessed on mobile devices. The company provides essential tools and infrastructure tailored for wireless carriers, brands, mobile phone manufacturers, and media organizations. This ensures that optical messaging and associated commerce are straightforward, universal, and reliable across global markets. As a pioneer in QR code and mobile barcode marketing solutions, NeoMedia helps businesses connect with their target audiences more effectively.
Oasmia Pharmaceutical AB specializes in the development and commercialization of innovative drugs for human and veterinary oncology, primarily in Sweden. The company focuses on creating novel formulations based on established cytostatics, aimed at enhancing efficacy and reducing side effects compared to existing treatments. Oasmia's portfolio includes Apealea/Paclical, which has completed phase III clinical trials for ovarian cancer, and Docetaxel micellar, a patented formulation in pre-clinical stages for prostate cancer. Additionally, it offers Doxophos, a formulation of doxorubicin used for various cancers, and KB9520, which is in pre-clinical development to mitigate side effects of cytostatic treatments. In the veterinary sector, Oasmia markets Paccal Vet and Doxophos Vet for mammary carcinoma and lymphoma, respectively. The company also possesses proprietary technologies, including XR-17, which enhances solubility for oncology applications. Founded in 1988 and headquartered in Uppsala, Sweden, Oasmia Pharmaceutical is committed to advancing cancer treatment through its research in nanotechnology and patented formulations.
NeoMedia Technologies specializes in creating interactive experiences for print and broadcast media through the use of 2D barcodes and mobile networks. By enabling users to bypass lengthy URLs and cumbersome menus, NeoMedia facilitates real-time content delivery that can be easily accessed on mobile devices. The company provides essential tools and infrastructure tailored for wireless carriers, brands, mobile phone manufacturers, and media organizations. This ensures that optical messaging and associated commerce are straightforward, universal, and reliable across global markets. As a pioneer in QR code and mobile barcode marketing solutions, NeoMedia helps businesses connect with their target audiences more effectively.
Medicago Inc., a biotechnology company, focuses on the research, development, production, and commercialization of vaccines in Canada. The company develops its vaccines based on its proprietary technologies, including the plant-based Proficia technology and Virus-Like Particles (VLP) technology. Its product candidate includes H5N1 pandemic influenza VLP vaccine, which has completed a Phase I human clinical trial. The company is also developing H1N1 VLP vaccine for Influenza A/California/04/09 virus; and seasonal influenza vaccines. Medicago Inc. has collaboration agreements with Viridis S.A.; Genopole biopark to manufacture pandemic and seasonal influenza vaccines; and Philip Morris International to produce a therapeutic protein with a humancompatible glycosylation pattern. The company was incorporated in 1997 and is headquartered in Quebec City, Canada.
Resverlogix Corp. operates as a late-stage clinical biotechnology company. The company is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trials for patients with cardiovascular, chronic kidney, end-stage renal, neurodegenerative, fabry, peripheral artery, and other orphan diseases, as well as diabetes mellitus. Resverlogix Corp. is headquartered in Calgary, Canada.
WILEX a biopharmaceutical company, develops drugs and diagnostic agents to detect cancer, treat malignant tumours, and prevent metastases. Its product line includes RENCAREX, a phase III substance for the treatment of non-metastatic renal cell cancer; REDECTANE, a phase III substance for the treatment of renal mass; and MESUPRON, a phase II substance for the treatment of pancreatic and breast cancer. The company's products also comprise the MEK inhibitor WX-554, which is under Phase I clinical trial; and the other oncology projects, including PI3K inhibitor WX-037 and three antibody programmes under preclinical development. It has a strategic alliance with UCB Pharma S.A. to develop preclinical oncology portfolio. The company was founded in 1997 and is headquartered in Munich, Germany.
Allon Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing and marketing central nervous system therapies. Its preclinical drug candidate comprises AL-309 for the treatment of peripheral neuropathy. The company was formerly known as Neuro Discovery Inc. and changed its name to Allon Therapeutics Inc. in September 2004. Allon Therapeutics Inc. is headquartered in Vancouver, Canada.
Mobile Max Technologies Ltd specializes in developing and licensing unified communication solutions and mobile least cost routing technology for service providers, carriers, and IP/PBX providers in Israel. The company offers the MobileMax UC Suite, which enables carriers to deploy mobile applications featuring functionalities such as business and private calling, call forwarding, conference calling, and mobile VoIP services. Additionally, Mobile Max provides the MobileMax Server, a provisioning tool that customizes applications to meet specific customer needs and delivers them directly to users' mobile devices. Founded in 2004 and based in Tel Aviv, Mobile Max Technologies focuses on enhancing communication efficiency for its clients through innovative technology solutions.
Ashford Hospitality Trust, Inc., (Ashford) together with its subsidiaries, is a self-administered real estate investment trust (REIT) focused on investing in the hospitality industry. The Company owns its lodging investments and conducts its business through Ashford Hospitality Limited Partnership, its operating partnership. Ashford OP General Partner LLC, which is a wholly owned subsidiary of the Company, serves as the sole general partner of its operating partnership. It operates in two business segments within the hotel lodging industry: direct hotel investments and hotel financing. Direct hotel investments include owning hotels through either acquisition or new development. Hotel financing includes owning subordinate hotel-related mortgages through acquisition or origination. In August 2014, Ashford Hospitality Trust Inc acquired 357-room Fremont Marriott Silicon Valley hotel
Hybrigenics Pharma is a bio-pharmaceutical company with a focus on research and development of new targets and therapies against cancer.Hybrigenics Pharma has stopped the development of inecalcitol, a vitamin D receptor agonist.Hybrigenics Pharma's research program investigates the action of enzymes called Deubiquitinating Enzymes (DUBs) in the recycling of onco-proteins and the potential activity of proprietary patented DUB inhibitors against various cancer indications.
Tower Semiconductor Ltd., along with its subsidiaries Jazz Semiconductor Inc. and TowerJazz Japan, operates as TowerJazz, a leader in the global specialty foundry sector. The company specializes in manufacturing integrated circuits and offers a diverse array of customizable process technologies, including SiGe, BiCMOS, Mixed-Signal/CMOS, RFCMOS, CMOS Image Sensors, Power Management (BCD), and MEMS capabilities. TowerJazz is committed to facilitating a quick and accurate design cycle through its advanced design enablement platform. Additionally, it provides Technology Optimization Process Services (TOPS) for integrated device manufacturers (IDMs) and fabless companies seeking to enhance their capacity. The company boasts multi-fab sourcing capabilities with manufacturing facilities located in Israel, the United States, and Japan.
VeriTeQ is a technology company focused on animal and emergency identification solutions. Its products are utilized around the world in such applications as pet identification using its patented, FDA-approved implantable microchip; livestock identification and tracking using visual and radio frequency identification (RFID) ear tags; and global positioning systems (GPS) search and rescue beacons for use on aircraft, ships and boats, and by adventure enthusiasts. The company was founded in 1993 and headquartered in Delray Beach, Florida.